- Home
- FATE vs PROV Comparison
FATE vs PROV Comparison
Compare FATE & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- PROV
- Stock Information
- Founded
- FATE 2007
- PROV 1956
- Country
- FATE United States
- PROV United States
- Employees
- FATE N/A
- PROV N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- PROV Savings Institutions
- Sector
- FATE Health Care
- PROV Finance
- Exchange
- FATE Nasdaq
- PROV Nasdaq
- Market Cap
- FATE 125.7M
- PROV 100.7M
- IPO Year
- FATE 2013
- PROV 1996
- Fundamental
- Price
- FATE $1.15
- PROV $15.30
- Analyst Decision
- FATE Hold
- PROV Hold
- Analyst Count
- FATE 7
- PROV 1
- Target Price
- FATE $3.58
- PROV $16.50
- AVG Volume (30 Days)
- FATE 1.5M
- PROV 4.7K
- Earning Date
- FATE 08-12-2025
- PROV 07-28-2025
- Dividend Yield
- FATE N/A
- PROV 3.71%
- EPS Growth
- FATE N/A
- PROV N/A
- EPS
- FATE N/A
- PROV 0.93
- Revenue
- FATE $8,470,000.00
- PROV $39,666,000.00
- Revenue This Year
- FATE N/A
- PROV $10.39
- Revenue Next Year
- FATE N/A
- PROV $1.56
- P/E Ratio
- FATE N/A
- PROV $16.45
- Revenue Growth
- FATE N/A
- PROV 1.90
- 52 Week Low
- FATE $0.66
- PROV $12.98
- 52 Week High
- FATE $4.20
- PROV $16.70
- Technical
- Relative Strength Index (RSI)
- FATE 53.09
- PROV 48.11
- Support Level
- FATE $1.06
- PROV $15.10
- Resistance Level
- FATE $1.18
- PROV $15.57
- Average True Range (ATR)
- FATE 0.09
- PROV 0.21
- MACD
- FATE 0.02
- PROV -0.00
- Stochastic Oscillator
- FATE 72.73
- PROV 48.72
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.